查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1470829

人工血管市场：按原料、产品、应用和最终用户划分 - 全球预测 2024-2030

Vascular Graft Market by Raw Material (Biological Materials, Polyester, Polytetrafluoroethylene), Product (Coronary Artery By-Pass Graft, Endovascular Stent Graft, Hemodialysis Access Graft), Application, End-User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年血管移植市场规模为35.1亿美元，预计2024年将达37.7亿美元，2030年将达57.9亿美元，复合年增长率为7.39%。

血管移植是一种外科手术，使用取自身体其他部位的血管（也称为移植物）将血流重定向到心臟中阻塞或部分阻塞的动脉。人造血管可由多种材料製成，包括聚四氟乙烯（PTFE）和聚氨酯等合成聚合物，以及胶原蛋白和人类或动物组织等生物材料。血管疾病的盛行率不断增加，以及易患心血管疾病的老年人口不断增加，导致血管移植的采用增加。然而，血管移植物植入后併发症的风险，例如移植物感染和血栓，可能会进一步阻碍血管移植物的采用。也就是说，开发先进生物相容性移植物的生医材料研究的兴起以及 3D血管造影术等血管成像技术的进步有可能为市场提供显着的成长机会。

主要市场统计
基准年[2023] 35.1亿美元
预测年份 [2024] 37.7亿美元
预测年份 [2030] 57.9亿美元
复合年增长率（%） 7.39%

由于原料的生物相容性和弹性，聚四氟乙烯血管移植物的使用迅速增加。

人体隐静脉、脐静脉等生物材料製成的人造血管因其生物相容性高、在人体内排斥的可能性低而广泛应用。这些材料表现出合理的相容性、优异的长期通畅性和最小的抗原性。这些材料优选用于需要较小直径的血管移植物，例如下肢绕道手术和冠状动脉绕道手术手术。组织工程材料旨在模仿天然生物组织，具有高度生物相容性和生物分解性。组织工程移植物的目标是提供活自体骨移植，可以与患者一起生长、重塑和自我修復，同时降低移植物失败、感染和排斥的风险。聚酯移植物具有高拉伸强度，但弹性往往不如天然血管。另一方面，PTFE虽然不如聚酯耐用，但具有较高的血液相容性，并且由于其弹性和优异的生物相容性而更常用。聚氨酯是一种有用的材料，因为它的硬度、弹性、弹性和生物稳定性等特性可以调节。

产品广泛使用周边血管移植物来恢復週边动脉阻塞患者的血流

冠状动脉绕道手术手术（CABG）是一种透过手术将冠状动脉连接到主动脉或大静脉以绕过心臟阻塞并维持血流的手术。当患者患有多发性动脉疾病、左主动脉疾病或冠状动脉疾病的严重症状时，通常会进行冠状动脉绕道手术。血管内血管支架是由金属网支撑的织物製成的管子，用于治疗腹部主动脉血管瘤等疾病。是手术风险高或拒绝开放性手术的患者的首选。透过手术植入血液透析机通路移植物，为慢性肾臟病病患者的血液透析机治疗提供持久且可靠的网路基地台。当患者的血管不适合创建动静脉（AV）瘻管时，这是首选。週边人造血管有助于恢復大脑和心臟以外区域的血流。它主要用于周边动脉疾病，并已被证明对週边动脉阻塞的患者有益。

应用：人造血管在心血管疾病治疗的重要用途

动脉瘤被定义为血管壁的异常扩张或隆起，通常需要用血管移植物进行治疗。这些移植物利用合成材料或自体组织绕过动脉瘤部位，有助于防止破裂和随后的严重后果。该领域的新发展导致了用于治疗腹主动脉瘤和胸主动脉瘤的血管内覆膜血管支架的发展，为传统开放性手术提供了微创治疗方法。心血管疾病是人造血管扮演重要角色的另一个领域。冠状动脉疾病、周边动脉疾病和大面积心肌梗塞都需要使用这些移植物。外科医生在冠状动脉绕道手术术 (CABG) 和周边搭桥术等手术中使用移植物来恢復缺血区域的血流并降低心臟病发病率和死亡率。糖尿病引起週边血管疾病，其特征通常是周边动脉闭塞和狭窄病变。人造血管，包括自体静脉和合成材料，用于绕过这些阻塞，帮助恢復灌注并降低截肢的风险。肾衰竭，尤其是末期肾功能衰竭（ESRD），需要血液透析机来挽救生命。这个过程需要可靠的血管通路，透过创建动静脉瘻管（AVF）或移植物（AVG）来实现连续透析通路。血管闭塞涉及血管的阻塞或闭合，是需要使用血管移植物的常见疾病。人造血管可作为恢復血液流动的管道，并且能够承受身体的自然动态动力。根据阻塞的位置和严重程度，通常采用由生物材料、生物相容性材料或合成材料製成的腔内覆膜支架或旁路移植物。

最终使用者：血管移植物在门诊手术中心（ASC）的重要应用

在门诊手术中心 (ASC)，通常会进行搭桥手术和支架置入等手术，通常需要放置血管移植物。 ASG 专注于提供具有成本效益的高品质护理，从而提高康復率和患者满意度，从而导致血管移植物的使用激增。随着医院进行越来越复杂的手术，对人造血管的需求持续成长。医院使用的移植物需要与各种手术相容，因此需要多种选择。传统上，医院专注于需要人造血管的复杂手术。然而，微创手术的增加和成本削减趋势正在推动向 ASC 的转变。

区域洞察

由于技术进步、医疗保健成本增加以及心血管疾病和糖尿病的流行，美洲的血管移植市场正在发展。在欧洲、中东和非洲地区，对监管合规性和安全措施的高度重视、强有力的研发计划、对血管移植物认识的提高以及医疗基础设施的发展正在推动血管移植物使用效果的改善。在亚太地区，由于文明病的增加、医疗保健服务的加速扩张以及医疗技术的显着进步，人工血管治疗方法的发展正在取得进展。此外，模仿天然血管结构和成分的生物工程人造血管的发展预计将增加医疗专业人员对这种医疗程序的使用，以治疗各种医疗状况。

FPNV定位矩阵

FPNV定位矩阵对于评估血管移植市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对血管移植市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵见解，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略，从而在市场上获得竞争优势。

本报告在以下方面提供了宝贵的见解：

1. 市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2. 市场开拓：我们深入研究利润丰厚的新兴市场，并分析其在成熟细分市场的渗透率。

3. 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4. 竞争评估和情报：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。

5. 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1.人造血管市场规模及预测如何？

2.在血管人工血管市场的预测期内，有哪些产品、细分市场、应用和领域需要考虑投资？

3.血管移植市场的技术趋势和法规结构是什么？

4.血管移植市场主要厂商的市场占有率是多少？

5.进入血管移植市场的合适型态和策略性手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地与文明病的发生率正在增加。
      • 人们对微创手术的兴趣日益浓厚
      • 血管移植临床试验增加
    • 抑制因素
      • 人工血管手术治疗费用高
    • 机会
      • 改善血管移植物的设计和性能
      • 利用组织工程开发血管移植
    • 任务
      • 血管移植相关感染疾病
  • 市场区隔分析
    • 原料：聚四氟乙烯血管移植物的使用由于其生物相容性和弹性而迅速增加。
    • 产品：增加使用周边血管移植物来恢復週边动脉阻塞患者的血流
    • 应用：血管移植物在治疗心血管疾病的重要用途
    • 最终使用者：血管移植物在门诊手术中心（ASC）的重要应用
  • 市场扰动分析
  • 波特五力分析
  • 价值炼和关键路径分析
  • 价格分析
  • 技术分析
  • 专利分析
  • 贸易分析
  • 法规结构分析

第六章 人工血管市场：依原料分类

  • 生物材料
  • 聚酯纤维
  • 聚四氟乙烯
  • 聚氨酯

第七章人工血管市场：副产品

  • 冠状动脉绕道手术绕道手术
  • 血管内覆膜血管支架
  • 血液透析机通路移植物
  • 周边设备人工血管

第八章人造血管市场：依应用分类

  • 动脉瘤
  • 心血管
  • 糖尿病
  • 肾衰竭
  • 血管闭塞

第九章人工血管市场：依最终用户分类

  • 门诊手术中心
  • 医院

第十章北美和南美人工血管市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太人工血管市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的人工血管市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Aquedeon Medical, Inc. 的 Duett 人工血管系统获得 FDA IDE核准
    • Xeltis 的 aXess 血管移植开发获得欧洲创新委员会的资助
    • Vygon 与 Carmat 合作开发用于人工心臟的人造血管
  • 战略分析和建议

第14章竞争产品组合

  • 主要企业简介
  • 主要产品系列
Product Code: MRR-034B50030374

[189 Pages Report] The Vascular Graft Market size was estimated at USD 3.51 billion in 2023 and expected to reach USD 3.77 billion in 2024, at a CAGR 7.39% to reach USD 5.79 billion by 2030.

A vascular graft is a surgical process that redirects blood flow around a blocked or partially blocked artery in the heart by using a blood vessel taken from another part of your body, also known as a graft. Vascular grafts can be made from various materials, including synthetic polymers, such as polytetrafluoroethylene (PTFE) and polyurethane, and biological materials, such as collagen and human or animal tissue. The rise in the prevalence of vascular disorders and the rise in the geriatric population prone to cardiovascular diseases increases the adoption of vascular grafts. However, the risk of complications post-implantation of a vascular graft, such as graft infection and blood clots, may further hinder the adoption of the vascular graft. Nevertheless, the rise of biomaterial research for developing advanced, biocompatible grafts and the ongoing advancements in vascular imaging technologies such as 3D angiography offer potential for significant growth opportunities for the market.

KEY MARKET STATISTICS
Base Year [2023] USD 3.51 billion
Estimated Year [2024] USD 3.77 billion
Forecast Year [2030] USD 5.79 billion
CAGR (%) 7.39%

Raw Material: Burgeoning utilization of polytetrafluoroethylene-based vascular grafts owing to their biocompatibility and flexibility

The vascular grafts made from biological materials, including human saphenous and umbilical veins, are used widely due to their inherent compatibility and decreased chances of rejection in the human body. They display moderate compliance, excellent long-term patency, and minimal antigenicity. These materials are preferred for vascular grafts that require a smaller diameter, such as lower extremity bypass procedures or coronary artery bypass grafting. Tissue-engineered materials are engineered to mimic the natural body tissue and have the advantage of being biocompatible and biodegradable. The goal of tissue-engineered grafts is to provide a living, autologous construct that could grow with the patient, remodel, and repair itself while reducing the risk of graft failure, infection, and rejection. Polyester grafts exhibit enhanced tensile strength; they tend to be less compliant than natural blood vessels. PTFE, on the other hand, while not as durable as polyester, presents high hemocompatibility and is more commonly used due to its flexibility and superior biocompatibility. Polyurethane is a useful material due to its tunable properties, including variable hardness, flexibility, elasticity, and biostability.

Product: Proliferating usage of peripheral vascular graft for restoring blood flow in patients with blockages in the peripheral arteries

Coronary Artery Bypass Graft (CABG) is a surgically created connection between the coronary artery and aorta or larger veins that enables blood flow to bypass blockage in the heart. CABG is generally preferred when the patient has multiple artery diseases, left main coronary artery disease, or severe symptoms of coronary artery disease. An endovascular stent graft is a tube comprised of fabric supported by a metal mesh used to treat ailments such as abdominal aortic aneurysms. The patient population with a high surgical risk or refusal of open surgery prefers this. Hemodialysis access grafts are surgically implanted to provide a durable and reliable access point for hemodialysis treatments in patients with chronic kidney disease. They are preferred when patients' vessels are not suitable for creating arteriovenous (AV) fistula. Peripheral vascular grafts help restore blood flow to the parts of the body other than the brain and the heart. Used primarily in cases of peripheral artery disease, these grafts prove beneficial for patients with blockages in the peripheral arteries.

Application: Significant use of vascular grafts in treating cardiovascular diseases

Aneurysms, defined as abnormal extensions or bulges in blood vessel walls, often require intervention through vascular grafts. These grafts, utilizing synthetic materials or autogenous tissue, are used to bypass the aneurysmal site, helping to prevent rupture and subsequent serious consequences. New developments in the field have led to the creation of endovascular stent grafts for treating abdominal and thoracic aortic aneurysms, offering a less invasive alternative to traditional open surgery. Cardiovascular disease is another area where vascular grafts have a pivotal role. Coronary artery disease, peripheral artery disease, and massive myocardial infarction necessitate the use of these grafts. Surgeons utilize them for procedures such as coronary artery bypass grafting (CABG) and peripheral bypass procedures, restoring blood flow to ischemic areas, subsequently reducing cardiac morbidity and mortality. Diabetes often leads to peripheral vascular disease characterized by occlusive and stenotic lesions in the peripheral arteries. Vascular grafts, including autologous veins and synthetic materials, are used for bypassing these occluded sections, helping restore perfusion and reducing the risk of limb amputations. Renal or kidney failure, specifically end-stage renal disease (ESRD), requires life-saving hemodialysis. This process mandates reliable vascular access, achieved through the creation of arteriovenous fistulae (AVF) or grafts (AVG) for continuous dialysis access. Vascular occlusion, relating to blockage or closure of blood vessels, is a common condition necessitating the use of vascular grafts. Vascular grafts serve as conduits to restore blood flow, able to withstand the body's natural hemodynamic forces. Intraluminal stent grafts or bypass grafts, comprising biological, biocompatible, or synthetic materials, are often employed depending on the location and extent of occlusion.

End-User: Significant applications of vascular grafts in ambulatory surgical centers (ASCs)

Ambulatory Surgical Centers (ASCs) commonly perform procedures such as bypass surgery or placing stents, which often require the implantation of vascular grafts. The ASGs are witnessing a surge in vascular graft usage due to their focus on providing cost-effective, high-quality care that results in improved recovery and better patient satisfaction. Hospital-based procedures requiring vascular grafts remain high, with a constantly growing need due to complex surgeries being performed. Grafts deployed in the hospital setting often need to serve diverse surgical requirements, necessitating a broad portfolio of options. Hospitals have been traditionally more centered on complicated surgeries requiring vascular grafts. However, the rise in minimally invasive procedures and the trend towards cost-saving is shifting preferences towards ASCs.

Regional Insights

The vascular graft market is evolving in the Americas owing to technological advancements, rising healthcare expenditure, and the prevalence of cardiovascular disorders and diabetes in the region. Strong focus on regulatory compliance and safety measures, substantial research and development projects, increasing awareness regarding vascular grafts, and growing healthcare infrastructure encourage using vascular graft procedures to improve treatment outcomes in the EMEA region. Growing prevalence of lifestyle diseases and the accelerating expansion of healthcare services, significant medical technology advancements are resulting in the development of enhanced vascular graft procedures in the APAC region. Besides, the development of bioengineered vascular grafts that mimic the natural blood vessel structure and composition is anticipated to increase the use of this medical procedure by health professionals to treat various medical conditions.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Vascular Graft Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Vascular Graft Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Vascular Graft Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Affluent Medical, B. Braun Melsungen AG, Becton, Dickinson and Company, BIOVIC Sdn. Bhd., Boston Scientific Corporation, Cardinal Health Inc., Cook Medical, Inc., Corcym S.r.l., CryoLife, Inc., Endologix Inc., Getinge AB, Heart Medical Europe B.V., Japan Lifeline Co., Ltd., Lemaitre Vascular, Inc., Medtronic PLC, Merit Medical Systems, Inc., Perouse Medical SAS by Vygon SAS, Rua Life Sciences PLC, Shanghai Suokang Medical Implants Co. Ltd., Terumo Corporation, Vascular Graft Solutions Ltd., VUP Medical, W. L. Gore & Associates, Inc., and Xeltis B.V..

Market Segmentation & Coverage

This research report categorizes the Vascular Graft Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Raw Material
    • Biological Materials
      • Human Saphenous & Umbilical Veins
      • Tissue Engineered Materials
    • Polyester
    • Polytetrafluoroethylene
    • Polyurethane
  • Product
    • Coronary Artery By-Pass Graft
    • Endovascular Stent Graft
    • Hemodialysis Access Graft
    • Peripheral Vascular Graft
  • Application
    • Aneurysm
    • Cardiovascular
    • Diabetes
    • Kidney Failure
    • Vascular Occlusion
  • End-User
    • Ambulatory Surgical Center
    • Hospital
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Vascular Graft Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Vascular Graft Market?

3. What are the technology trends and regulatory frameworks in the Vascular Graft Market?

4. What is the market share of the leading vendors in the Vascular Graft Market?

5. Which modes and strategic moves are suitable for entering the Vascular Graft Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of lifestyle-related disorders globally
      • 5.1.1.2. Growing preference for minimally invasive procedures
      • 5.1.1.3. Rising number of clinical trials of vascular grafts
    • 5.1.2. Restraints
      • 5.1.2.1. High treatment cost of vascular graft procedures
    • 5.1.3. Opportunities
      • 5.1.3.1. Improvements in the design and performance of vascular grafts
      • 5.1.3.2. Development of tissue-engineered vascular grafts
    • 5.1.4. Challenges
      • 5.1.4.1. Infections associated with vascular grafts
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Raw Material: Burgeoning utilization of polytetrafluoroethylene-based vascular grafts owing to their biocompatibility and flexibility
    • 5.2.2. Product: Proliferating usage of peripheral vascular graft for restoring blood flow in patients with blockages in the peripheral arteries
    • 5.2.3. Application: Significant use of vascular grafts in treating cardiovascular diseases
    • 5.2.4. End-User: Significant applications of vascular grafts in ambulatory surgical centers (ASCs)
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Vascular Graft Market, by Raw Material

  • 6.1. Introduction
  • 6.2. Biological Materials
  • 6.3. Polyester
  • 6.4. Polytetrafluoroethylene
  • 6.5. Polyurethane

7. Vascular Graft Market, by Product

  • 7.1. Introduction
  • 7.2. Coronary Artery By-Pass Graft
  • 7.3. Endovascular Stent Graft
  • 7.4. Hemodialysis Access Graft
  • 7.5. Peripheral Vascular Graft

8. Vascular Graft Market, by Application

  • 8.1. Introduction
  • 8.2. Aneurysm
  • 8.3. Cardiovascular
  • 8.4. Diabetes
  • 8.5. Kidney Failure
  • 8.6. Vascular Occlusion

9. Vascular Graft Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Center
  • 9.3. Hospital

10. Americas Vascular Graft Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Vascular Graft Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Vascular Graft Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Aquedeon Medical, Inc. Receives FDA IDE Approval for the Duett Vascular Graft System
    • 13.3.2. Xeltis' aXess Vascular Graft Development Receives Funding From European Innovation Council
    • 13.3.3. Vygon Partners with Carmat to Develop a Vascular Graft for an Artificial Heart
  • 13.4. Strategy Analysis & Recommendation

14. Competitive Portfolio

  • 14.1. Key Company Profiles
  • 14.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. VASCULAR GRAFT MARKET RESEARCH PROCESS
  • FIGURE 2. VASCULAR GRAFT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VASCULAR GRAFT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VASCULAR GRAFT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL VASCULAR GRAFT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. VASCULAR GRAFT MARKET DYNAMICS
  • FIGURE 7. GLOBAL VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL VASCULAR GRAFT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL VASCULAR GRAFT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. VASCULAR GRAFT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 24. VASCULAR GRAFT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VASCULAR GRAFT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VASCULAR GRAFT MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL VASCULAR GRAFT MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL VASCULAR GRAFT MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL VASCULAR GRAFT MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL VASCULAR GRAFT MARKET SIZE, BY HUMAN SAPHENOUS & UMBILICAL VEINS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL VASCULAR GRAFT MARKET SIZE, BY HUMAN SAPHENOUS & UMBILICAL VEINS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL VASCULAR GRAFT MARKET SIZE, BY TISSUE ENGINEERED MATERIALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL VASCULAR GRAFT MARKET SIZE, BY TISSUE ENGINEERED MATERIALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYESTER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYESTER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYTETRAFLUOROETHYLENE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL VASCULAR GRAFT MARKET SIZE, BY POLYURETHANE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL VASCULAR GRAFT MARKET SIZE, BY CORONARY ARTERY BY-PASS GRAFT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL VASCULAR GRAFT MARKET SIZE, BY CORONARY ARTERY BY-PASS GRAFT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL VASCULAR GRAFT MARKET SIZE, BY ENDOVASCULAR STENT GRAFT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL VASCULAR GRAFT MARKET SIZE, BY ENDOVASCULAR STENT GRAFT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL VASCULAR GRAFT MARKET SIZE, BY HEMODIALYSIS ACCESS GRAFT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL VASCULAR GRAFT MARKET SIZE, BY HEMODIALYSIS ACCESS GRAFT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PERIPHERAL VASCULAR GRAFT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL VASCULAR GRAFT MARKET SIZE, BY PERIPHERAL VASCULAR GRAFT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL VASCULAR GRAFT MARKET SIZE, BY ANEURYSM, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL VASCULAR GRAFT MARKET SIZE, BY ANEURYSM, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL VASCULAR GRAFT MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL VASCULAR GRAFT MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL VASCULAR GRAFT MARKET SIZE, BY DIABETES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL VASCULAR GRAFT MARKET SIZE, BY DIABETES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL VASCULAR GRAFT MARKET SIZE, BY KIDNEY FAILURE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL VASCULAR GRAFT MARKET SIZE, BY KIDNEY FAILURE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL VASCULAR GRAFT MARKET SIZE, BY VASCULAR OCCLUSION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL VASCULAR GRAFT MARKET SIZE, BY VASCULAR OCCLUSION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL VASCULAR GRAFT MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL VASCULAR GRAFT MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL VASCULAR GRAFT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL VASCULAR GRAFT MARKET SIZE, BY HOSPITAL, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 51. AMERICAS VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 52. AMERICAS VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 53. AMERICAS VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 54. AMERICAS VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 55. AMERICAS VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 56. AMERICAS VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 57. AMERICAS VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 58. AMERICAS VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 59. AMERICAS VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 60. AMERICAS VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 61. AMERICAS VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 62. AMERICAS VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 63. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 64. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 65. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 66. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 67. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 68. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 69. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 70. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 71. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 72. ARGENTINA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 73. BRAZIL VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 74. BRAZIL VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 75. BRAZIL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 76. BRAZIL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 77. BRAZIL VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 78. BRAZIL VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 79. BRAZIL VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 80. BRAZIL VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 81. BRAZIL VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 82. BRAZIL VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 83. CANADA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 84. CANADA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 85. CANADA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 86. CANADA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 87. CANADA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 88. CANADA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 89. CANADA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 90. CANADA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 91. CANADA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 92. CANADA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 93. MEXICO VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 94. MEXICO VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 95. MEXICO VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 96. MEXICO VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 97. MEXICO VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 98. MEXICO VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 99. MEXICO VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 100. MEXICO VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 101. MEXICO VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 102. MEXICO VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 103. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 104. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 105. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 106. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 107. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 108. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 109. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 110. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 111. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 112. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 113. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 114. UNITED STATES VASCULAR GRAFT MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 127. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 128. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 129. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 130. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 131. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 132. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 133. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 134. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 135. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 136. AUSTRALIA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 137. CHINA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 138. CHINA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 139. CHINA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 140. CHINA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 141. CHINA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 142. CHINA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 143. CHINA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 144. CHINA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 145. CHINA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 146. CHINA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 147. INDIA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 148. INDIA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 149. INDIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 150. INDIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 151. INDIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 152. INDIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 153. INDIA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 154. INDIA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 155. INDIA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 156. INDIA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 157. INDONESIA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 158. INDONESIA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 159. INDONESIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 160. INDONESIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 161. INDONESIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 162. INDONESIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 163. INDONESIA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 164. INDONESIA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 165. INDONESIA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 166. INDONESIA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 167. JAPAN VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 168. JAPAN VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 169. JAPAN VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 170. JAPAN VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 171. JAPAN VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 172. JAPAN VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 173. JAPAN VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 174. JAPAN VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 175. JAPAN VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 176. JAPAN VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 177. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 178. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 179. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 180. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 181. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 182. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 183. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 184. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 185. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 186. MALAYSIA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 187. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 188. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 189. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 190. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 191. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 192. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 193. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 194. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 195. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 196. PHILIPPINES VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 197. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 198. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 199. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 200. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 201. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 202. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 203. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 204. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 205. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 206. SINGAPORE VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 207. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 208. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 209. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 210. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 211. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 212. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 213. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 214. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 215. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 216. SOUTH KOREA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 217. TAIWAN VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 218. TAIWAN VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 219. TAIWAN VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 220. TAIWAN VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 221. TAIWAN VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 222. TAIWAN VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 223. TAIWAN VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 224. TAIWAN VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 225. TAIWAN VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 226. TAIWAN VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 227. THAILAND VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 228. THAILAND VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 229. THAILAND VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 230. THAILAND VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 231. THAILAND VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 232. THAILAND VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 233. THAILAND VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 234. THAILAND VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 235. THAILAND VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 236. THAILAND VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 237. VIETNAM VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 238. VIETNAM VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 239. VIETNAM VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 240. VIETNAM VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 241. VIETNAM VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 242. VIETNAM VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 243. VIETNAM VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 244. VIETNAM VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 245. VIETNAM VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 246. VIETNAM VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA VASCULAR GRAFT MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 259. DENMARK VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 260. DENMARK VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 261. DENMARK VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 262. DENMARK VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 263. DENMARK VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 264. DENMARK VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 265. DENMARK VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 266. DENMARK VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 267. DENMARK VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 268. DENMARK VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 269. EGYPT VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 270. EGYPT VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 271. EGYPT VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 272. EGYPT VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 273. EGYPT VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 274. EGYPT VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 275. EGYPT VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 276. EGYPT VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 277. EGYPT VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 278. EGYPT VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 279. FINLAND VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 280. FINLAND VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 281. FINLAND VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 282. FINLAND VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 283. FINLAND VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 284. FINLAND VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 285. FINLAND VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 286. FINLAND VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 287. FINLAND VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 288. FINLAND VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 289. FRANCE VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 290. FRANCE VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 291. FRANCE VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 292. FRANCE VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 293. FRANCE VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 294. FRANCE VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 295. FRANCE VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 296. FRANCE VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 297. FRANCE VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 298. FRANCE VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 299. GERMANY VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 300. GERMANY VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 301. GERMANY VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 302. GERMANY VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 303. GERMANY VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 304. GERMANY VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 305. GERMANY VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 306. GERMANY VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 307. GERMANY VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 308. GERMANY VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 309. ISRAEL VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 310. ISRAEL VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 311. ISRAEL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 312. ISRAEL VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 313. ISRAEL VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 314. ISRAEL VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 315. ISRAEL VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 316. ISRAEL VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 317. ISRAEL VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 318. ISRAEL VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 319. ITALY VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 320. ITALY VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 321. ITALY VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 322. ITALY VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 323. ITALY VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 324. ITALY VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 325. ITALY VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 326. ITALY VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 327. ITALY VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 328. ITALY VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 329. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 330. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 331. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 332. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 333. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 334. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 335. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 336. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 337. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 338. NETHERLANDS VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 339. NIGERIA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 340. NIGERIA VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 341. NIGERIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 342. NIGERIA VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 343. NIGERIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 344. NIGERIA VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 345. NIGERIA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 346. NIGERIA VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 347. NIGERIA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 348. NIGERIA VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 349. NORWAY VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 350. NORWAY VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 351. NORWAY VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 352. NORWAY VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 353. NORWAY VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 354. NORWAY VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 355. NORWAY VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 356. NORWAY VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 357. NORWAY VASCULAR GRAFT MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 358. NORWAY VASCULAR GRAFT MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 359. POLAND VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2018-2023 (USD MILLION)
  • TABLE 360. POLAND VASCULAR GRAFT MARKET SIZE, BY RAW MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 361. POLAND VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2023 (USD MILLION)
  • TABLE 362. POLAND VASCULAR GRAFT MARKET SIZE, BY BIOLOGICAL MATERIALS, 2024-2030 (USD MILLION)
  • TABLE 363. POLAND VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 364. POLAND VASCULAR GRAFT MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 365. POLAND VASCULAR GRAFT MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 366. POLAND VAS